Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer
NCT07463690 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2026-03-11
Summary
This multicenter randomized controlled trial aims to develop and evaluate the effectiveness of a "Flipped Discharge" intervention for colorectal cancer patients with a new intestinal stoma. Guided by the Response to Transition Theory, the model addresses the care gap during the vulnerable post-discharge period by shifting critical support from the hospital to the patient's home. Approximately 200 eligible patients will be randomized into either the intervention or standard care control group. The core "Flipped Discharge" intervention occurs on the third day post-discharge, delivered either as an in-home visit by a specialist stoma nurse (via an "Internet + Nursing Service" platform) or as an intensive, standardized video follow-up with mailed instructional materials. The study's primary outcome is the incidence of stoma-related complications. Secondary outcomes include quality of life, self-care ability, self-efficacy, stoma adaptation, discharge readiness, healthcare costs, and satisfaction. The trial will also explore the mechanisms by which the intervention affects patient outcomes, ultimately seeking to provide evidence for a feasible, patient-centered model to improve care continuity.
Conditions
- Colorectal Cancer
- Stoma
Interventions
- BEHAVIORAL
-
Response to Transition Theory-based Flipped Discharge Model
This is a structured, multi-component continuing care intervention initiated after hospital discharge for colorectal cancer patients with an intestinal stoma. Based on the Response to Transition Theory, it aims to support patients' adaptation during the critical early post-discharge period. The core intervention is a standardized assessment and education session conducted around the third day post-discharge. This is delivered flexibly based on patient location: either an in-home visit by a certified enterostomal therapist via a hospital-approved "Internet + Nursing Service" platform, or a standardized, intensive video follow-up (≥30 minutes) coupled with a mailed stoma care kit for those outside the service area. The intervention is complemented by protocol-driven telephone follow-ups on days 1-2 and at 1 week to reinforce education, provide psychological support, and address individual concerns.
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-10
- Primary Completion
- 2027-12-30
- Completion
- 2027-12-30
Countries
- China
Study Locations
More Related Trials
-
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
NCT05353582 ·Status: UNKNOWN ·Phase: PHASE2
-
The CSTME Associates With the Prognosis of Stage II and III Colorectal Cancer
NCT05420415 ·Status: COMPLETED
-
Fecal Microbiota Transplantation for Radiation-Induced Proctopathy
NCT06776029 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer
NCT06637215 ·Status: RECRUITING ·Phase: NA
-
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482 ·Status: UNKNOWN
-
A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects
NCT07319364 ·Status: RECRUITING ·Phase: PHASE1
-
Postoperative Effects of Different Enterostomy Approaches
NCT05853094 ·Status: RECRUITING ·Phase: NA
-
Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer (NORESTO Study)
NCT06194708 ·Status: RECRUITING
-
The Safety and Efficiency of Stent-based Diverting Technique Versus Ileostomy in Rectal Cancer Patients
NCT06204497 ·Status: COMPLETED ·Phase: NA
-
Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy
NCT06980350 ·Status: COMPLETED
-
Effect Analysis of Neoadjuvant Chemoradiotherapy Combined With Surgery in Laparoscope for Advanced Colon Cancer
NCT05279612 ·Status: UNKNOWN
-
Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients
NCT05797467 ·Status: RECRUITING ·Phase: PHASE3
-
The Impact of Immune Cell Changes During the Perioperative Period on the Prognosis of Patients With Colorectal Cancer
NCT05015296 ·Status: UNKNOWN
-
Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA)
NCT06205862 ·Status: RECRUITING ·Phase: PHASE2
-
Mix Vaccine for Metastatic Colorectal Cancer
NCT03357276 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status
NCT05610592 ·Status: COMPLETED
-
Virtual Ileostomy Versus Diverting Ileostomy in Patients Undergoing Total Mesorectal Excision
NCT06633133 ·Status: RECRUITING ·Phase: NA
-
Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer
NCT06614660 ·Status: ACTIVE_NOT_RECRUITING
-
A Prospective Multicentre Clinical Study of Dynamic Monitoring of Plasma ctDNA Methylation Markers to Predict Recurrence of Colorectal Cancer After Complete Resection of Peritoneal Metastases
NCT06903325 ·Status: RECRUITING
-
Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer
NCT06557668 ·Status: RECRUITING
-
Preoperative Chemoradiotheray for Rectal Cancer
NCT00819559 ·Status: UNKNOWN ·Phase: NA
-
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
NCT05815082 ·Status: RECRUITING ·Phase: PHASE3
-
Transanal Versus Laparoscopic Total Mesorectal Excision: a Cohort
NCT05682794 ·Status: COMPLETED
-
Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer
NCT00689364 ·Status: UNKNOWN